Search - tctmd.com

Displaying 101 - 120 of 156

Sort: Relevancy | Date

Presentation NY Valves 2024

Screening for Transcatheter Native Mitral Valve Intervention: Echocardiography

Presenter: Akhil Narang

June 05, 2024

News Conference News NY Valves 2024

Reassuring 5-Year Outcomes for Sapien-Treated TAVI Patients With Small Annuli

Michael O'Riordan

June 05, 2024

Presentation NY Valves 2024

First-in-Human Clinical Trial of a Robotic TEE System for Diagnostics and Interventional Guidance (ROB'E)

Presenter: Jury Schewel

June 05, 2024

Presentation NY Valves 2024

An Automated Echocardiogram Screening Program to Optimize Treatment of Mitral Regurgitation: A Single Center Experience

Presenter: Bharat Ravishankar

June 05, 2024

Presentation NY Valves 2024

Current and Future use of Artificial Intelligence in Echocardiography

Presenter: Akhil Narang

June 05, 2024

Presentation NY Valves 2024

Echocardiographic Speckle Strain Imaging and Valvular Heart Disease Outcomes

Presenter: Madalina Garbi

June 05, 2024

Presentation NY Valves 2024

AI-Powered Cardiac Ultrasound Improves Identification of High-Risk Aortic Stenosis (EchoIQ)

Presenter: Pedro Covas

June 05, 2024

Presentation NY Valves 2024

Risk Stratification for Aortic Regurgitation: Echo or CMR?

Presenter: Joao L. Cavalcante

June 05, 2024

Presentation NY Valves 2024

Assessing Severity of Mixed Valve Disease Based on Multi-Modality Imaging and Echo Hemodynamics

Presenter: Anjali Sharma

June 05, 2024

News Opinion CV Team Dispatch

June 2024 Dispatch for the CV Team

L.A. McKeown

June 01, 2024

News Conference News HRS 2024

CASA-AF: Similar 3-Year Efficacy for Surgical and Catheter Ablation

L.A. McKeown

May 23, 2024

News Conference News ESOC 2024

Medicare Analysis Suggests Benefit of PFO Closure Beyond Age 60

Todd Neale

May 17, 2024

Presentation EuroPCR 2024

Early outcomes of a randomised non-inferiority trial comparing TAVI devices: the LANDMARK trial

Presenter: Patrick Serruys

May 15, 2024

News Conference News EuroPCR 2024

ORBITA-2: Angina Phenotype Strongly Predicts PCI Response

Caitlin E. Cox

May 15, 2024

News Conference News EuroPCR 2024

Myval Matches Contemporary TAVI at 30 Days, but Do More Sizes Matter?

Shelley Wood

May 15, 2024

Presentation EuroPCR 2024

Short Methodology Insight - LANDMARK

Presenter: Davide Capodanno

May 14, 2024

News Conference News ESC Heart Failure 2024

Delays to Echo and Diagnosis Spell Poor Early Outcomes in Suspected HF

Michael O'Riordan

May 13, 2024

News Daily News

New HCM Guidelines Focus on Cardiac Myosin Inhibitors and Exercise

Yael L. Maxwell

May 08, 2024

News Industry News

Biosense Webster Launches New Version of CARTO™ 3 Electro-Anatomical Mapping System

May 08, 2024

Advertisement

Screening for Transcatheter Native Mitral Valve Intervention: Echocardiography

Reassuring 5-Year Outcomes for Sapien-Treated TAVI Patients With Small Annuli

First-in-Human Clinical Trial of a Robotic TEE System for Diagnostics and Interventional Guidance (ROB'E)

An Automated Echocardiogram Screening Program to Optimize Treatment of Mitral Regurgitation: A Single Center Experience

Current and Future use of Artificial Intelligence in Echocardiography

Echocardiographic Speckle Strain Imaging and Valvular Heart Disease Outcomes

AI-Powered Cardiac Ultrasound Improves Identification of High-Risk Aortic Stenosis (EchoIQ)

Risk Stratification for Aortic Regurgitation: Echo or CMR?

Assessing Severity of Mixed Valve Disease Based on Multi-Modality Imaging and Echo Hemodynamics

June 2024 Dispatch for the CV Team

CASA-AF: Similar 3-Year Efficacy for Surgical and Catheter Ablation

Medicare Analysis Suggests Benefit of PFO Closure Beyond Age 60

Early outcomes of a randomised non-inferiority trial comparing TAVI devices: the LANDMARK trial

ORBITA-2: Angina Phenotype Strongly Predicts PCI Response

Myval Matches Contemporary TAVI at 30 Days, but Do More Sizes Matter?

Short Methodology Insight - LANDMARK

Delays to Echo and Diagnosis Spell Poor Early Outcomes in Suspected HF

New HCM Guidelines Focus on Cardiac Myosin Inhibitors and Exercise

Biosense Webster Launches New Version of CARTO™ 3 Electro-Anatomical Mapping System

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content